News
Video
At this year's ASCRS meeting in Boston, Massachusetts, Leonard Borrmann, CEO at Centricity Vision, about the company's new product ZEPTOLink, including first-in-human data.
At this year's ASCRS meeting in Boston, Massachusetts, Leonard Borrmann, CEO at Centricity Vision, about the company's new product ZEPTOLink, including first-in-human data.
Editor's note: The below transcript has been lightly edited for clarity.
I'm Leonard Borrmann, and I'm the CEO at Centricity Vision. And I'm here at ASCRS, where we're launching our new product ZEPTOLink. We're really excited about ZEPTOLink. ZEPTOLink is the first and only product that's capable of creating a 360-degree, instantaneous, capsulotomy. Earlier this week, and Eyecelerator, I presented some of our first in-man data on ZEPTOLink. We had 4 doctors do 61 cases of patients undergoing cataract surgery, treated with ZEPTOLink. All 61 of the patients had complete capsulotomies with no signs of tags or tears. The results in terms of capsulotomy diameter and circularity were extremely precise. A capsulotomy, size at 5.1, and circularity very, very low at five one-hundredths of a millimeter. We're really excited about the data, the procedure itself was all performed in less than 13 seconds, in all cases. It's very cost-effective in terms of getting it into the operating room. And we're really excited about the possibilities that ZEPTOLink brings in terms of improving outcomes for your premium patients, making complex cases just a little less challenging, and most importantly, doing all of that in a very productive, efficient and cost-effective manner.